Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT01529840
First received: January 2, 2012
Last updated: April 29, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)